Position Statement: Micropressure Therapy
April 18, 2022the Meniett device) in certain cases of Meniere’s disease. Micropressure therapy can be used as a second level therapy when medical treatment has failed. The device represents a largely non-surgical therapy that should be available as one of the many treatments for Meniere…
Position Statement: Electrocochleography
April 18, 2022Arenberg IK (Ed.). Kugler Publications, Amsterdam/New York, 1993:477-485. Kitahara, M., T. Takeda, et al. Electrocochleography in the diagnosis of Meniere's disease. Meniere's disease. Pathogenesis, diagnosis and treatment. . Vosteen KH, Schuknecht H and P. C. e. al. New York, Thieme-Stratton…
Ménière’s Disease: New Clinical Practice Guideline to Enhance Diagnostic Accuracy and Treatment
April 19, 2022discusses the background on possible causes of Ménière’s disease, disorders that present similarly to it, and the ways in which the disease can progress. “The guideline aims to reduce the subjectivity of diagnosis and treatment for Ménière’s disease and to provide some objective…
CPG Test Page
August 21, 2023opportunities in postoperative pain management of common otolaryngologic surgical procedures Read more Purpose: To improve the quality of the diagnostic workup and treatment outcomes of Ménière’s disease (MD) Read more Purpose: To identify quality improvement opportunities in the management of nosebleeds and to create…
CPG: Ménière’s Disease - Research Needs
April 19, 2022Research Needs section from Ménière’s Disease CPG Clinical epidemiologic studies to standardize categories of disease stage, severity, and treatment response, as well as optimal follow-up time frames for outcome assessment. Development and validation of clinically relevant measures of QOL. Identification of true pathophysiology…
Clinical Practice Guideline: Ménière’s Disease
April 25, 2023here for instructions on how to customize these handouts. Frequently Asked Questions (FAQs) about Ménière’s Disease Frequently Asked Questions (FAQs) about Ménière’s Disease Triggers Frequently Asked Questions (FAQs) about Ménière’s Disease Frequently Asked Questions (FAQs) about Ménière’s Disease Triggers Preguntas Frecuentes…
Clinical Practice Guideline: Ménière’s Disease
April 13, 2021This guideline was published in the April 2020 issue of Otolaryngology–Head and Neck Surgery. Clinical Practice Guideline: Ménière’s Disease published in Otolaryngology–Head and Neck Surgery on April 8. This clinical practice guideline (CPG) is intended for all for all health care providers…
CPT for ENT: Gentamicin Injections
December 1, 2023The administration of gentamicin injections is a common procedure performed by otolaryngologists for severe cases of vertigo when observed in some patients with Meniere’s disease. The gentamicin deadens the hair-like fibers that transmit balance information to the brain. Initially, the injections may cause…
CPT for ENT: Transtympanic Therapeutic Injections
December 1, 2023Transtympanic therapeutic injections are a common procedure performed by otolaryngologists for various otologic conditions, such as sudden sensorineural hearing loss and severe cases of vertigo when observed in some patients with Meniere’s disease. A patient may use any variety of medications, and the patient…
Position Statement: Red Flags-Warning of Ear Disease
September 23, 2021with the following “red flags”: Hearing loss with a positive history of ear infections, noise exposure, familial hearing loss, TB, syphilis, HIV, Meniere’s disease, autoimmune disorder, ototoxic medication use, otosclerosis, von Recklinghausen’s neurofibromatosis, Paget’s disease of bone, ear or head trauma related…
Position Statement: Vestibular Myogenic Potential (VEMP) Testing
September 23, 2021at ANA annual meeting, Chicago Oct 9, 2006. Rauch SD and others. Vestibular evoked myogenic potentials show altered tuning in patients with Meniere's disease. Otol Neurotol 25:333-338, 2004. Important Disclaimer Notice (Updated 7/31/14) Position statements are approved by the American…